Diaceutics PLC (AIM: DXRX)
Health Care · Life Sciences Tools & Services · GB
£1.40
+0.72% today · +1.5% 1Y
Diaceutics PLC (AIM: DXRX) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $161.54M.
Over the last twelve months the share price has gained 1.5%, trading between 1.25 and 1.80.
Tweenvest scores Diaceutics PLC across four factors: quality 73/100, value 54/100, growth 98/100. Its strongest factor is growth.
DXRX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $161.54M
- Revenue (TTM)
- $51.73M
- P/E
- —
- EPS
- 0.00
- Dividend yield
- —
- Beta (5Y)
- 0.89
- 52-week high
- £1.80
- 52-week low
- £1.25
- Avg volume (3M)
- —
- Shares outstanding
- 84.88M
- Employees
- —
- Next earnings
- —
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $232.47B | $628.74 | -0.08% |
| Danaher CorporationNYSE: DHR | $151.22B | $215.11 | -1.71% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $69.06B | CN¥155.84 | -4.31% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $51.21B | CHF587.80 | -0.74% |
| Agilent Technologies, Inc.NYSE: A | $43.33B | $153.43 | -3.50% |
| IQVIA Holdings Inc.NYSE: IQV | $42.77B | $260.24 | +0.16% |
| Waters CorporationNYSE: WAT | $40.36B | $410.75 | +0.01% |
Figures last refreshed Aug 18, 2026.